Monitor the July 1 special meeting vote; approval is likely given Horowitz's voting control (75.5%), but the majority-of-minority condition requires separate approval from shares excluding insiders. Key swing votes include Edenbrook Capital (9.3% voting power). If approved, the deal closes quickly; watch for conversion of notes into common stock and earn-out milestones over the next 24 months.
Price Chart
Executive Summary
Marchex is seeking stockholder approval to acquire Archenia, a performance-based marketing tech company, from insiders including its Chairman and Vice Chairman for $10M in convertible notes (6% interest, convertible at $1.80/share) plus up to 4M earn-out shares. The special committee and board unanimously recommend approval. The deal is structured as a related-party transaction with a fairness opinion from Craig-Hallum. Stockholder approval is required by both a majority of all shares and a majority excluding interested directors.
Key Financial Metrics
Key Facts
- Marchex to acquire Archenia for $10M in convertible promissory notes (6% interest, 3 tranches over 24 months) convertible at $1.80/share.
- Up to 4M additional earn-out shares (2M per 12-month period) contingent on revenue/EBITDA and integration/customer retention targets.
- Sellers include Russell Horowitz (Chairman, 75.5% voting power) and Michael Arends (Vice Chairman); special committee of independent directors negotiated the deal.
- Craig-Hallum provided fairness opinion deeming $16.52M total consideration (notes + max earn-out) fair from a financial point of view.
- Vote requires both a majority of all shares and a 'majority of the minority' excluding Horowitz and Arends; no appraisal rights.
- Special meeting on July 1, 2026; expected close promptly thereafter if approved.
- Archenia had 2025 revenue of $18.0M and net loss of $131K; pro forma combined revenue for 2025 would be $63.3M.
Financial Impact
Base consideration $10M in convertible notes (plus ~$150K annual interest); earn-out up to 4M shares (~9% dilution at current shares outstanding). Combined 2025 revenue $63.3M vs Marchex standalone $45.4M; combined net loss $5.97M.
Risk Factors
- Related-party transaction creates potential conflicts; earn-out metrics may be disputed.
- Archenia has a material weakness in internal controls and a history of limited audited financials.
- Conversion of notes and earn-out shares could dilute existing shareholders significantly.
- Integration and customer retention risks; 75% customer retention required for earn-out.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| DEFM14A Filing (Primary) | 0002077096-26-000195 |
| Document: 0002077096-26-000195-index-headers.html | 0002077096-26-000195 |
| Document: 0002077096-26-000195-index.html | 0002077096-26-000195 |
| Document: 0002077096-26-000195.txt | 0002077096-26-000195 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 22, 2026 4w ago | Press Release | $1.42 $1.28 | ▼ −9.86% | ▼ −9.30% | $1.26 (−11.27%) |
Aug 12, 2026 10w ago | 8-K | $1.82 $1.37 | ▼ −25.00% | ▼ −23.25% | $1.26 (−30.77%) |
Jun 5, 2026 20w ago | DEFM14A | $1.53 $1.76 | ▲ +15.03% | ▲ +13.40% | $1.26 (−17.65%) |
May 26, 2026 21w ago | PREM14A | $1.63 $1.50 | ▼ −7.98% | ▼ −6.07% | $1.26 (−22.70%) |
May 13, 2026 23w ago | 8-K | $1.62 $1.55 | ▼ −4.32% | ▼ −3.46% | $1.26 (−22.22%) |
May 13, 2026 23w ago | DEFA14A | $1.62 $1.55 | ▼ −4.32% | ▼ −3.46% | $1.26 (−22.22%) |
May 1, 2026 25w ago | 8-K | $1.73 $1.67 | ▼ −3.47% | ▼ −9.11% | $1.26 (−27.17%) |
Apr 17, 2026 27w ago | 10-K/A | $1.72 $1.66 | ▼ −3.49% | ▼ −7.69% | $1.26 (−26.74%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers